LONDON (Reuters) -A U.S. ban on copycat versions of Novo Nordisk's Wegovy has begun to lift use of the weight loss drug, but the company will need to show more robust growth in the months ahead to ...

Novo Nordisk A/S (NYSE:NVO) is one of the top low volatility healthcare stocks to buy now. In a report released on July 17, ...

The U.S. FDA ban on compounded versions of Novo Nordisk's Wegovy has increased its prescriptions by 33%. Despite this, ...

The market value of the company surpassed the size of Denmark’s entire economy last year and, for a period, Novo Nordisk was ...

CVS acknowledged that Zepbound has been shown to help people lose more weight than Wegovy, but that Wegovy can still help ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

The US struck a framework trade agreement with the European Union on Sunday, imposing a 15% import tariff on most EU goods.

The United States and the European Union have reached a framework trade agreement, imposing a 15 per cent import tariff on ...

These five upcoming data drops could usher in more effective and convenient therapies for Alzheimer’s disease and open up ...

The U.S. struck a framework trade agreement with the European Union on Sunday, imposing a 15% import tariff on most EU goods ...

By Twesha Dikshit (Reuters) -European shares advanced to a four-month high on Monday, led by gains in pharma and ...

Global pharmaceutical giants make billions of dollars in Australia but pay a fraction of that in tax. They say the price they ...